⌘K
Loading ticker…
As of 2026-08-21, Envoy Medical, Inc. Class A Common Stock (COCH) has a 3-month relative strength percentile of 52 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 46. The current market Stance is 49.9 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.1%, relative volume 0.48×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
COCH is held by 2 ETFs as of Mar 2026. Top owner: VXF at 0.00% weight, $405K notional.
Held by 3 ETFs · $604K across latest filings · largest weight 0.00% (IWC).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VXFVanguard Extended Market ETF | 0.00% | $405K | — |
| VTIVanguard Total Stock Market ETF | 0.00% | $182K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | COCH Jan avg: -7.18% median: -1.69% win: 33% σ: 26.44% n: 3 2023-10-03 → 2026-07-31 | COCH Feb avg: 100.00% median: 11.45% win: 67% σ: 179.01% n: 3 2023-10-03 → 2026-07-31 | COCH Mar avg: -10.02% median: -8.17% win: 0% σ: 6.05% n: 3 2023-10-03 → 2026-07-31 | COCH Apr avg: 6.63% median: 8.42% win: 100% σ: 3.82% n: 3 2023-10-03 → 2026-07-31 | COCH May avg: -11.13% median: 3.75% win: 67% σ: 28.72% n: 3 2023-10-03 → 2026-07-31 | COCH Jun avg: 1.74% median: -0.42% win: 33% σ: 9.63% n: 3 2023-10-03 → 2026-07-31 | COCH Jul avg: -7.27% median: -9.32% win: 33% σ: 9.25% n: 3 2023-10-03 → 2026-07-31 | COCH Aug avg: 12.68% median: 12.68% win: 50% σ: 40.22% n: 2 2023-10-03 → 2026-07-31 (current) | COCH Sep avg: -14.66% median: -14.66% win: 50% σ: 31.50% n: 2 2023-10-03 → 2026-07-31 | COCH Oct avg: -29.75% median: -18.46% win: 33% σ: 40.38% n: 3 2023-10-03 → 2026-07-31 | COCH Nov avg: 24.90% median: 4.25% win: 67% σ: 52.34% n: 3 2023-10-03 → 2026-07-31 | COCH Dec avg: -26.01% median: -21.22% win: 0% σ: 9.80% n: 3 2023-10-03 → 2026-07-31 |